Dermia Conticare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 9 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.70 M
as on 17-07-2024
- Revenue -2.43%
(FY 2023)
- Profit -64.67%
(FY 2023)
- Ebitda 171.18%
(FY 2023)
- Net Worth 20.17%
(FY 2023)
- Total Assets 27.13%
(FY 2023)
About Dermia Conticare
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.70 M.
Ashwani Mehta and Kamaljit Singh serve as directors at the Company.
- CIN/LLPIN
U24232CH2015PTC035853
- Company No.
035853
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dermia Conticare Private Limited offer?
Dermia Conticare Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Skin Care Cosmetics, Hand Sanitizers & Personal Hygiene, Herbal Soaps, Child and Baby Care Products, Baby Care Products, Common Disease Medicines, Hair Growth Medicine, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder.
Who are the key members and board of directors at Dermia Conticare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwani Mehta  | Director | 14-Sep-2017 | Current |
| Kamaljit Singh | Director | 14-Dec-2015 | Current |
Financial Performance of Dermia Conticare.
Dermia Conticare Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.43% decrease. The company also saw a substantial fall in profitability, with a 64.67% decrease in profit. The company's net worth Soared by an impressive increase of 20.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dermia Conticare?
In 2023, Dermia Conticare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asterisk Laboratories India Private LimitedActive 10 years 10 monthsAshwani Mehta is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 25 May 2022 | ₹2.70 M | Open |
How Many Employees Work at Dermia Conticare?
Unlock and access historical data on people associated with Dermia Conticare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dermia Conticare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dermia Conticare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
